Navigating Thymoma Treatment: Systemic Agents and Checkpoint Inhibitors

This chapter explores treatment options for thymoma, emphasizing systemic agents used in both first-line and recurrent therapies. It highlights the importance of combination therapies and discusses the role and risks of checkpoint inhibitors in relation to autoimmune disorders.